Lungpacer Medical, Inc.
New Form D on file · 2026-04-28 · the record
Lungpacer Medical, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-28.
Lungpacer Medical, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 28, 2026. The filing reports $12M sold. Its industry group is Other Health Care. It names Douglas Evans (Chief Executive Officer and President), Joseph Kaufmann (Director), Bob Donohue (Director) (SEC Form D, April 28, 2026).
In its own words: “Discover the Lungpacer® System, a medical device designed to stimulate the diaphragm and support patient care in clinical settings.” (lungpacer.com, checked October 31, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Lungpacer Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lungpacer Medical, Inc.
Free to see. No signup.
More on the people and the money behind Lungpacer Medical, Inc., from the filings we hold.
Other Health Care raises by companies based in Pennsylvania, filed in April 2026, largest first.
Get an email when Lungpacer Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lungpacer Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lungpacer Medical, Inc. →Get the full cited report on Lungpacer Medical, Inc.
What the filing shows about Lungpacer Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lungpacer Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lungpacer Medical, Inc.'s address as 260 Sierra Drive, Suite 116, Exton, PA 19341.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Lungpacer Medical, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Lungpacer Medical, Inc. See pricing
Lungpacer Medical, Inc. is a registered filer with the SEC (CIK 1708893) and has filed since 2025-04-01. 3 filings are on record, the latest on 2026-10-14.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lungpacer Medical, Inc.'s Form D of 2026-04-28 names Douglas Evans, Joseph Kaufmann, Bob Donohue and 5 more as its officers, directors or promoters.
Its new offerings report $29.83M sold across 3 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $12M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Douglas Evans is named as Chief Executive Officer and President on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
Joseph Kaufmann is named as Director on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
Bob Donohue is named as Director on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Christopher Kiple is named as Chair of the Board on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
Jan Pensaert is named as Director on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Jonathan Conlin is named as Secretary on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Rosemarie Dhavale is named as Chief Financial Officer and Vice President of Hr on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
On the filing as: Executive Officer.
Viral Thakkar is named as Chief Operations Officer on the Form D that Lungpacer Medical, Inc. filed with the SEC on 28 April 2026, one of 8 people that filing names.
8 people named on the filing — 5 holding an executive role and 3 as directors only.
Named as of the 2026-04-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lungpacer Medical, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Lungpacer Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lungpacer Medical, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lungpacer Medical, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lungpacer Medical, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lungpacer Medical, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Philadelphia
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/lungpacer-medical-inc-form-d-26000001